Image by Getty Images via Daylife Volume 3, Number 22 May 31, 2006 Stocks sold off sharply again yesterday, but they’ve held above last week’s lows. Falling consumer confidence and rising interest rates were named as reasons for the move out of equities. Of… Read More
Our seasoned team of analysts continually monitors investment opportunities around the world, to provide investors with the widest possible array of money-making ideas.
Analyst Articles
We took a loss on our Advance Micro Devices put option following news that Dell Computer will begin shipping high-end servers equipped with AMD Opteron chips. The Dell announcement isn’t a big deal to AMD and we had thought such a hook up was priced into AMD’s stock. Investors’ initial… Read More
Image by squareintheteeth via Flickr Volume 3, Number 21 May 24, 2006 When you’re losing money it’s easy to forget that corrections in the context of bull markets are a common occurrence. Pullbacks of 3 to 5 percent can occur at any time. Pullbacks of… Read More
Our Chevron September 60 call option (CVX + IL) is a buy here. Chevron (CVX) has announced plans to expand the capacity of a deep water crude oil pipeline in the Gulf of Mexico, anticipating increased new discoveries. Also, Exxon announced the discovery of oil in a deepwater field off… Read More
Image via Wikipedia Volume 3, Number 20 May 17, 2006 The Fed hiked short-term interest rates last week, as expected. Only the central bank failed to make clear its intentions for going forward. The markets have been in a tizzy ever since. Bernanke and Co. are… Read More
Chevron (CVX) still looks very attractive, but we were running short of time with the June 65 call option (CVX + FM). That’s why we took a hit on the position this morning, rolling the trade into the longer-dated September 60 call option (CVX + IL). It’s a buy at… Read More
Image by Getty Images via Daylife Volume 3, Number 19 May 10, 2006 All eyes are on the Fed today, looking for indications of the central bank’s next move. It’s widely expected the Fed will announce its 16th consecutive quarter-point hike in short-term interest… Read More
We’ve relatively few changes to our holdings since the late update. Yesterday we took our lumps on the Genentech June 80 call option trade, booking a 66 percent loss. The biotech sector is down about 14 percent from its February peak, despite outstanding results from lead players such as Genentech… Read More
Image via Wikipedia Volume 3, Number 18 May 3, 2006 Amylin’s shares are off sharply from their recent highs because demand for its diabetes drug Byetta is outpacing the company’s production capabilities. More specifically, if growth continues at its current month-over-month pace of 20 to… Read More
We generated a few taxable events in the past week, but not everything has gone as planned. Even in a service as nimble as The Aggressive Trader, it can sometimes be difficult trading in a fast moving market. Last week, for instance, the sharp one-day correction in gold and the… Read More